Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Fosbretabulin tromethamine

EU orphan designation number: EU/3/13/1154   
Active ingredient: Fosbretabulin tromethamine
Indication: Treatment of ovarian cancer
Sponsor: Diamond BioPharm Limited
No 4 East Wing Gemini House, Flex Meadow, Harlow, Essex CM19 5TJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2013 Orphan designation EMA/OD/039/13 (2013)4728 of 17/07/2013